Literature DB >> 6349203

Clinical application of the 24-H urinary C-peptide excretion rate and its relationship to metabolic control in diabetics.

R Pasquali, P Biso, G Baraldi, L Mattioli, M Capelli, F Pasqui, N Melchionda.   

Abstract

In this study, we evaluated in normal subjects, insulin-dependent (IDD) and non-insulin-dependent (NIDD) diabetics, the diurnal urinary C-peptide excretion rate (CPR-U) and its relationship to serum C-peptide concentration and glucose:C-peptide molar ratio, and to the common parameters of metabolic control. The CPR-U (and CPR-U/g creatinine) were significantly lower in IDD and higher in NIDD compared to control subjects. Moreover, a good and significant correlation with serum C-peptide concentrations and the glucose:C-peptide ratio in diabetic subjects as well as in controls and diabetics considered together was found. A slight but significant correlation was present in diabetic subjects between CPR-U and body mass index (r = 0.45), 24-h glycosuria (r = 0.36), HbA1 levels (r = 0.31), post-prandial glucose concentrations (r = 0.26) and per cent glucose variation after each meal (r = 0.34). No differences were found in CPR-U and the degree of metabolic control between obese and non-obese NIDD. In conclusion, CPR-U may be a useful and simple method of defining the secretory activity of the B-cell. Metabolic control in diabetics is slightly correlated to the degree of B-cell function as evaluated by the diurnal excretion rate of C-peptide in urine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6349203     DOI: 10.1007/bf02624916

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  19 in total

1.  Enzymic determination of D(-)-beta-hydroxybutyric acid and acetoacetic acid in blood.

Authors:  D H WILLIAMSON; J MELLANBY; H A KREBS
Journal:  Biochem J       Date:  1962-01       Impact factor: 3.857

2.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

4.  Hemoglobin components in patients with diabetes mellitus.

Authors:  L A Trivelli; H M Ranney; H T Lai
Journal:  N Engl J Med       Date:  1971-02-18       Impact factor: 91.245

5.  C-peptide metabolism and the liver.

Authors:  C Kühl; O K Faber; P Hornnes; S L Jensen
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

6.  Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine.

Authors:  D L Horwitz; A H Rubenstein; A I Katz
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

7.  Human C-peptide immunoreactivity (CPR) in blood and urine - evaluation of a radioimmunoassay method and its clinical applications.

Authors:  T Kuzuya; T Saito; S Yoshida; A Matsuda
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122

8.  Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.

Authors:  J Mirouze; J L Selam; T C Pham; E Mendoza; A Orsetti
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

9.  Insulin therapy in relation to circulating C-peptide levels.

Authors:  W Beischer; W Kerner; S Raptis; L Keller; B Beischer; E F Pfeiffer
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

10.  Kinetics of human C-peptide in man.

Authors:  O K Faber; H Kehlet; S Madsbad; C Binder
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.